Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quintiles, UMMC in First Asian Prime Site Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Quintiles, UMMC in First Asian Prime Site Pact

Quintiles boosts clinical infrastructure in Asia

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quintiles has formed a strategic alliance agreement with the University Malaya Medical Centre (UMMC) as part of its unique Prime Site program, an initiative focused on accelerating the development of new and more effective medicines. The UMMC is the first Prime Site in Asia for Quintiles, adding to its existing four other sites located in the U.S., Europe and Africa. Prime Sites are large clinical institutions that collaborate with Quintiles to enhance their infrastructure for conducting clinical trials.

Quintiles chief medical and scientific officer Christopher Cabell M.D. remarked, “UMMC is an ideal partner for us because of its experience in conducting clinical research, its access to substantial patient populations and its clinical expertise across multiple therapeutic areas. Through this new alliance, Quintiles will be able to significantly improve its reach to patients and investigators who are critical to facilitating the increasingly complex therapies under development.”

Anand Tharmaratnam, M.D., senior vice president and head of Clinical Development for Quintiles Asia-Pacific, added, “Malaysia is an increasingly important player in Asia-Pacific clinical drug development and the commitment of its government, academic and private industry leaders to promoting leading-edge clinical research in the country is undeniable. This, coupled with the highly skilled clinical workforce, strong clinical research infrastructure and large potential patient populations makes Malaysia and UMMC a quality fit as our first Prime Site in Asia. With the enthusiasm and vision for this model that our UMMC partner has shown, we are confident that this will serve as a strong foundation for our Prime Site program in Asia.”

Quintiles opened its first office in the region in 1993 and now has more than 20 offices in 14 countries throughout the region, with its regional headquarters in Singapore.

Read Dr. Tharmaratnam’s article Realizing the Promise of Asia-Pacific in the June 2010 issue of Contract Pharma!

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics